3rd Quarter - Report
THE D MAJOR GROUP for EMD SERONO, INC.
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Monitor issues concerning "march-in" rights as related to pharmaceutical research and development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Medicare/Medicaid MMM
Monitor provisions related to federal price negotiation, Part D redesign and excise tax as included in H.R. 5376, the "Inflation Reduction Act." Also work on HR 19 and S. 2164, the Lower Costs More Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Pharmacy PHA
Monitor FDA User Fee Reauthorization measures as included in HR 6833, the "Continuing Appropriations & Ukraine Supplemental Appropriations Act."
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Repub. Policy Com't. |
| BRENDA REESE | Conference Coordinator for House Republican Conf. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.